PUMA BIOTECHNOLOGY, INC. - COM (PBYI)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024: Q1 2024
Type / Class: Equity / COM
Shares, excl. options Q1 2024: 28.9 M
Holdings value Q1 2024: $153 M
Value change Q1 2024: +$15.8 M
Grand Portfolio weight change Q1 2024: +0%
Number of holders: 89
Number of buys Q1 2024: 53
Number of sells Q1 2024: -34
Average buys Q1 2024 %: +0%
Average sells Q1 2024 %: -0.001%
CUSIP: 74587V107

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2024 Q1	28.9 M	$153 M	+$15.8 M	171 K	4.46 M	$5.30	89
2023 Q4	26.2 M	$114 M	+$4.61 M	107 K	667 K	$4.33	78
2023 Q3	25.7 M	$67.6 M	-$2.43 M	185 K	705 K	$2.63	67
2023 Q2	26.6 M	$93.8 M	-$4.38 M	156 K	1.14 M	$3.53	67
2023 Q1	27.9 M	$86.1 M	-$528 K	139 K	954 K	$3.09	76
2022 Q4	27.5 M	$116 M	-$150 K	168 K	461 K	$4.23	83
2022 Q3	27.5 M	$65.3 M	-$1.68 M	134 K	698 K	$2.37	68
2022 Q2	27.6 M	$78.6 M	-$4.2 M	154 K	131 K	$2.85	73
2022 Q1	29.4 M	$84.6 M	-$205 K	395 K	100 K	$2.88	93
2021 Q4	30.2 M	$91.8 M	-$38.9 M	326 K	657 K	$3.04	93
2021 Q3	31.7 M	$222 M	-$28.8 M	363 K	756 K	$7.01	111
2021 Q2	34.1 M	$313 M	-$20.3 M	541 K	858 K	$9.18	115
2021 Q1	36.5 M	$355 M	+$11.7 M	528 K	693 K	$9.72	114
2020 Q4	31.9 M	$328 M	-$10.2 M	2.92 M	3.57 M	$10.26	115
2020 Q3	38.6 M	$390 M	+$12.7 M	2.96 M	1.55 M	$10.09	121
2020 Q2	32.1 M	$335 M	-$7.02 M	3.44 M	1.63 M	$10.43	120
2020 Q1	31.6 M	$266 M	+$39.2 M	3.42 M	2.76 M	$8.44	111
2019 Q4	31.1 M	$272 M	-$65.2 M	5.37 M	4.96 M	$8.75	126
2019 Q3	33.3 M	$359 M	+$12.5 M	7.22 M	5.15 M	$10.77	131
2019 Q2	31.7 M	$403 M	-$100 M	2.7 M	3.74 M	$12.71	127
2019 Q1	33.2 M	$1.29 B	+$6.94 M	16.5 M	27.6 M	$38.79	152
2018 Q4	34.9 M	$711 M	-$233 M	9.93 M	5.2 M	$20.35	131
2018 Q3	35.6 M	$1.63 B	+$1.14 M	30.6 M	34.3 M	$45.85	152
2018 Q2	35.4 M	$2.09 B	+$48.1 M	58 M	60.3 M	$59.15	163
2018 Q1	35.6 M	$2.42 B	-$81.3 M	26.7 M	14.8 M	$68.05	165
2017 Q4	36.1 M	$3.57 B	-$112 M	65.7 M	62.9 M	$98.85	193
2017 Q3	36.7 M	$4.39 B	+$170 M	62.1 M	73.7 M	$119.75	170
2017 Q2	35.5 M	$3.1 B	+$54.1 M	109 M	107 M	$87.40	155
2017 Q1	37.9 M	$1.41 B	+$190 M	12.6 M	16.1 M	$37.20	134
2016 Q4	34.9 M	$1.07 B	+$72.9 M	4.7 M	16.4 M	$30.70	128
2016 Q3	30 M	$2.01 B	+$5.53 M	15.9 M	19.2 M	$67.05	146
2016 Q2	31.6 M	$942 M	+$45.4 M	5.35 M	2.09 M	$29.79	105
2016 Q1	30.3 M	$889 M	-$118 M	7.47 M	13 M	$29.37	113
2015 Q4	32.2 M	$2.52 B	+$179 M	29.4 M	65.2 M	$78.40	130
2015 Q3	30.1 M	$2.27 B	-$28.2 M	20.9 M	146 M	$75.36	158
2015 Q2	30.1 M	$3.52 B	-$43.6 M	37 M	41.1 M	$116.75	194
2015 Q1	29.1 M	$6.87 B	+$478 M	45.5 M	50.3 M	$236.11	196
2014 Q4	27.1 M	$5.14 B	+$67.8 M	42.5 M	27.8 M	$189.27	182
2014 Q3	26.7 M	$6.37 B	+$471 M	83.1 M	83.9 M	$238.57	185
2014 Q2	25.4 M	$1.67 B	-$31.6 M	20.1 M	39.8 M	$66.00	133
2014 Q1	25.1 M	$2.61 B	+$106 M	11.7 M	6.21 M	$104.14	129